Abiraterone Acetate Tablet
Product Images NDC 64980-418

5 FDA label images from Rising Pharma Holdings, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 64980-418). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rising Pharma Holdings, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Abiraterone Figure 1)

Figure 1 (Abiraterone Figure 1)
A Kaplan-Meier overall survival curve comparing Abiraterone acetate and placebo over 21 months. The y-axis represents the percentage survival, and the x-axis shows time to death in months. The graph includes sample size counts at various time points for both groups, with Abiraterone acetate indicated by a solid line and placebo by a dashed line.*
FDA Label Image

Figure 2 (Abiraterone Figure 2)

Figure 2 (Abiraterone Figure 2)
A survival curve chart comparing the percentage of subjects without death over months from randomization for Abiraterone acetate 250 mg tablets versus placebo. The x-axis represents the time in months, and the y-axis shows the percentage of surviving subjects. Two distinct curves indicate survival trends for the two groups over approximately 60 months.*
FDA Label Image

Figure 3 (Abiraterone Figure 3)

Figure 3 (Abiraterone Figure 3)
A Kaplan-Meier survival curve chart showing percentage of subjects without radiographic progression or death over time in months from randomization. Two curves compare Abiraterone acetate tablets versus placebo in a clinical study, with the number of subjects at risk at various time points displayed below the x-axis.*
FDA Label Image

Container Label (Abiraterone Label)

Container Label (Abiraterone Label)
Label for Abiraterone Acetate Tablets, USP 250 mg by Rising Pharma Holdings, Inc. The label indicates 120 tablets for oral use, prescription only, with a warning for pregnant women. It includes dosing information and storage instructions along with the NDC number 64980-418-12.*
FDA Label Image

Structure (Abiraterone Structure)

Structure (Abiraterone Structure)
Chemical structure of abiraterone acetate, showing its steroidal core with a pyridine ring and an acetate functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.